ATE184287T1 - Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen - Google Patents
Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungenInfo
- Publication number
- ATE184287T1 ATE184287T1 AT94929585T AT94929585T ATE184287T1 AT E184287 T1 ATE184287 T1 AT E184287T1 AT 94929585 T AT94929585 T AT 94929585T AT 94929585 T AT94929585 T AT 94929585T AT E184287 T1 ATE184287 T1 AT E184287T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- production
- therapeutically effective
- pharmaceutical preparations
- blood clotting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9311942A FR2710917B1 (fr) | 1993-10-07 | 1993-10-07 | Nouveaux dérivés de peptides thérapeutiquement actifs dans la cascade de coagulation sanguine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE184287T1 true ATE184287T1 (de) | 1999-09-15 |
Family
ID=9451616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94929585T ATE184287T1 (de) | 1993-10-07 | 1994-10-06 | Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5786330A (de) |
| EP (1) | EP0722460B1 (de) |
| JP (1) | JP2899415B2 (de) |
| CN (1) | CN1053451C (de) |
| AT (1) | ATE184287T1 (de) |
| AU (1) | AU680696B2 (de) |
| CA (1) | CA2173598A1 (de) |
| DE (1) | DE69420574T2 (de) |
| DK (1) | DK0722460T3 (de) |
| ES (1) | ES2138668T3 (de) |
| FI (1) | FI961505A (de) |
| FR (1) | FR2710917B1 (de) |
| GR (1) | GR3031254T3 (de) |
| NO (1) | NO961357L (de) |
| NZ (1) | NZ274524A (de) |
| WO (1) | WO1995009869A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1138694A1 (de) * | 2000-03-30 | 2001-10-04 | University Of Manitoba | Hirulog-ähnliches Peptid |
| WO2006045503A1 (en) | 2004-10-19 | 2006-05-04 | Lonza Ag | Method for solid phase peptide synthesis |
| US7598343B1 (en) | 2008-07-27 | 2009-10-06 | The Medicines Company | Pharmaceutical formulations of bivalirudin and processes of making the same |
| US7582727B1 (en) | 2008-07-27 | 2009-09-01 | The Medicinces Company | Pharmaceutical formulations of bivalirudin and processes of making the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2686086A1 (fr) * | 1992-01-15 | 1993-07-16 | Adir | Nouveaux derives de peptides et de pseudopeptides therapeutiquement actifs dans la cascade de coagulation sanguine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1993
- 1993-10-07 FR FR9311942A patent/FR2710917B1/fr not_active Expired - Fee Related
-
1994
- 1994-10-06 JP JP7510650A patent/JP2899415B2/ja not_active Expired - Fee Related
- 1994-10-06 DK DK94929585T patent/DK0722460T3/da active
- 1994-10-06 EP EP94929585A patent/EP0722460B1/de not_active Expired - Lifetime
- 1994-10-06 CA CA002173598A patent/CA2173598A1/fr not_active Abandoned
- 1994-10-06 NZ NZ274524A patent/NZ274524A/en unknown
- 1994-10-06 WO PCT/FR1994/001166 patent/WO1995009869A1/fr active IP Right Grant
- 1994-10-06 AT AT94929585T patent/ATE184287T1/de not_active IP Right Cessation
- 1994-10-06 ES ES94929585T patent/ES2138668T3/es not_active Expired - Lifetime
- 1994-10-06 CN CN94194052A patent/CN1053451C/zh not_active Expired - Fee Related
- 1994-10-06 AU AU78587/94A patent/AU680696B2/en not_active Ceased
- 1994-10-06 DE DE69420574T patent/DE69420574T2/de not_active Expired - Fee Related
- 1994-10-06 US US08/619,683 patent/US5786330A/en not_active Expired - Fee Related
-
1996
- 1996-04-02 NO NO961357A patent/NO961357L/no not_active Application Discontinuation
- 1996-04-03 FI FI961505A patent/FI961505A/fi unknown
-
1999
- 1999-09-20 GR GR990402347T patent/GR3031254T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO961357D0 (no) | 1996-04-02 |
| DK0722460T3 (da) | 2000-03-20 |
| EP0722460A1 (de) | 1996-07-24 |
| CN1053451C (zh) | 2000-06-14 |
| WO1995009869A1 (fr) | 1995-04-13 |
| EP0722460B1 (de) | 1999-09-08 |
| FR2710917A1 (fr) | 1995-04-14 |
| JPH09503221A (ja) | 1997-03-31 |
| NZ274524A (en) | 1996-12-20 |
| CA2173598A1 (fr) | 1995-04-13 |
| DE69420574D1 (de) | 1999-10-14 |
| FI961505A0 (fi) | 1996-04-03 |
| US5786330A (en) | 1998-07-28 |
| NO961357L (no) | 1996-06-06 |
| FR2710917B1 (fr) | 1995-11-24 |
| AU680696B2 (en) | 1997-08-07 |
| AU7858794A (en) | 1995-05-01 |
| CN1134706A (zh) | 1996-10-30 |
| DE69420574T2 (de) | 2000-05-04 |
| ES2138668T3 (es) | 2000-01-16 |
| FI961505A (fi) | 1996-04-03 |
| GR3031254T3 (en) | 1999-12-31 |
| JP2899415B2 (ja) | 1999-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG101118A (en) | Therapeutical compounds | |
| BR9714517A (pt) | Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
| IL127352A (en) | Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them | |
| YU46097A (sh) | Nova klasa estara i njihove farmaceutske smeše | |
| ATE140388T1 (de) | Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen | |
| GEP20012413B (en) | Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| HUP0000492A1 (hu) | N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával | |
| DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
| DE69326954D1 (de) | Amphiphile verbindungen abgegleitet von aminosäuren oder peptiden, verfahren zu ihrer herstellung und ihre verwendung als arzeimittelverabreichung | |
| DE69715439D1 (de) | Pyridylalkan-säureamide als cytostatika und immunosupressive arzneimittel | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| ATE439833T1 (de) | Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten | |
| RU93045145A (ru) | Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство | |
| DE69900756D1 (de) | Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung | |
| ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
| CY1105545T1 (el) | Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας | |
| ATE184287T1 (de) | Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen | |
| EE9600109A (et) | a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid | |
| DK82892D0 (da) | Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner | |
| ATE194076T1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
| SE9700244D0 (sv) | Novel antibacterial protein | |
| RU94046312A (ru) | Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные | |
| ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
| ZA824649B (en) | New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |